ETFs
N
NVO
Novo-Nordisk A/S
44.74
-1.06-2.31%After Hours: 44.47 -0.27 -0.60%19:59 05/15 EDT
OPEN/PREV CLOSE45.40/45.80
TODAY RANGE44.25-45.50
VOL16.38M
MARKET CAP198.49B
52 WEEK RANGE34.64-77.81
AVG VOL (3M)20.17M
% TURNOVER0.37%
TURNOVER--
P/E (TTM)10.56
% RANGE2.73%
EPS(TTM)4.235
P/E(FORWARD)10.13
P/B6.33
BVPS7.07
DIVIDEND1.802
P/S4.095
BETA--
DIV YIELD4.03%
FREE FLOAT MKT CAP198.48B
SHARES OUTSTANDING4.44B
NEXT EARNINGS--
FREE FLOAT4.44B
LOT SIZE1
EX-DATE03/30/2026
News
Press Releases
Financial Reports
Profile
The Motley Fool·10h ago
Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound?
Seeking Alpha·1d ago
FDA leadership fallout continues as acting CDER Director Hoeg expected to depart
The Motley Fool·2d ago
Buy, Sell, or Hold Novo Nordisk at $46?
The Motley Fool·2d ago
Hims & Hers Stock Drops After Earnings: Buying Opportunity or Warning Sign?
Seeking Alpha·2d ago
Novo Nordisk: The First Fruits Of Labor
Simply Wall St·2d ago
Novo Nordisk (NYSE:NVO) Valuation Check After Mixed Year To Date And 1 Year Share Returns
The Motley Fool·2d ago
Best Healthcare Stocks to Buy in 2026
Seeking Alpha·2d ago
Biopharmas look to China, elsewhere for partnerships, R&D
Seeking Alpha·2d ago
Strong biopharma dealmaking market set to continue
Seeking Alpha·2d ago
Hims & Hers Health Is Likely Dead Money
Seeking Alpha·3d ago
Novo Nordisk: Why I Won't Upgrade
Benzinga·3d ago
Trump's Drug Pricing Plan Gains Surprise Democratic Ally— Peter Welch Vows To 'Make It Happen'
Same Industry
Name/Symbol
Change%
Price